Cargando…
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
BACKGROUND: Approximately 50% of uveal melanoma (UM) patients develop metastases preferentially in the liver leading to death within 15 months. Currently, there is no effective treatment for metastatic UM, in part because the tumor burden is typically high when liver metastases are detected through...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399902/ https://www.ncbi.nlm.nih.gov/pubmed/30867659 http://dx.doi.org/10.1186/s12014-019-9230-8 |